Epinast Eye Drops 0.05% - 5 ml
৳ 150
Quantity:
1
SKU: T2M1861
Order By Call:
+88 01540 384 786 (Mobile)
+88 01819 479 004 (WhatsApp)
Payment Methods
About the Product
Full Description
\n
\n
\n \n
\n \n
\n \n
\nEtoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. Etoricoxib is a potent, orally active & highly selective cyclooxygenase-2 (COX-2) inhibitor. COX-2 is primarily responsible for the synthesis of prostanoid mediators of pain, inflammation and fever. Etoricoxib decreases these clinical signs and symptoms effectively with decreased GI toxicity. Moreover it has no effect on platelet function.
\n \n
\n \n
\n \n
\n \n \n
\nPresentation:
\nEtovan-60 Tablet: Each film coated tablet contains Etoricoxib INN 60 mg. Etovan-90 Tablet: Each film coated tablet contains Etoricoxib INN 90 mg. Etovan-120 Tablet: Each film coated tablet contains Etoricoxib INN 120 mg.
\n \n \n
\nIndication:
\nEtoricoxib is indicated for: •Acute and chronic treatment of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) •The management of ankylosing spondylitis (AS) •Treatment of acute gouty arthritis •Other acute & chronic musculoskeletal pain
\n \n \n
\nDosage & Administration:
\nThe recommended dose for adult and patient over 16 years: Acute pain: 120 mg once daily. Etoricoxib 120 mg should be used only for acute symptomatic period, limited to a maximum of 8 days treatment. Chronic musculoskeletal pain: 60 mg once daily. Osteoarthritis: 30 mg once daily, increased if necessary to 60 mg once daily. Rheumatoid arthritis and ankylosing spondylitis: 90 mg once daily. Acute gout: 120 mg once daily for max. 8 days. Max. 60 mg daily in mild hepatic impairment; max. 60 mg on alternate days or 30 mg once daily in moderate hepatic impairment.
\n \n \n
\nContrainidications:
\nHypersensitivity to any component of this product, severe hepatic impairment, inflammatory bowel disease, congestive heart failure, peripheral artery disease, established ischemia, uncontrolled hypertension (persistently above 140/90 mmHg) & breast-feeding mother.
\n \n \n
\nWarning & Precautions:
\nThe drug should be avoided in case of severe hepatic impairment and in renal impairment (if creatinine clearance less than 30 ml/ minute)
\n \n \n
\nSide effects:
\nDry mouth, taste disturbance, mouth ulcer, flatulence, constipation, appetite and weight changes, chest pain , fatigue, paraesthesia, influenza like syndrome, myalgia etc. may occur.
\n \n \n
\nDrug interaction:
\nWarfarin, Rifampicin, Methotrexate, ACE Inhibitor, Angiotensin II Antagonists, Lithium, Aspirin, Oral contraceptives may interact with Etoricoxib.
\n \n \n
\nUse in special groups:
\nUse in pregnancy: Etoricoxib should be avoided in late pregnancy. Use in nursing mother: Because of the possible adverse effects on nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug.
\n \n \n
\nPacking:
\nEtovan-60 Tablets: Each box contains 30's tablets in blister pack. Etovan-90 Tablet: Each box contains 30's tablets in blister pack. Etovan-120 Tablet: Each box contains 20’s tablets in blister pack.
\n
